Compare HubSpot Inc (HUBS) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HubSpot Inc vs Novartis AG — how do they compare? HubSpot Inc trades at $217.27 (market cap $11.84B), while Novartis AG trades at $149.81 (market cap $290.25B). The key difference: Novartis AG is far larger — about 24.5× HubSpot Inc's market cap, and Novartis AG pays a 3.17% dividend while HubSpot Inc pays none. Which is the better fit depends on your goals.
| HUBS | NVS | |
|---|---|---|
Market Cap | $11.84B | $290.25B |
Sector | Technology | Health |
52-Week High | $560.90 | $168.62 |
52-Week Low | $170.39 | $113.50 |
Enterprise Value | $10.39B | $330.27B |
Dividend Yield | — | 3.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HubSpot Inc
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
Read more on HUBS →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
